Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China

被引:24
作者
Bian, LG
Tirakotai, W
Sun, QF
Zhao, WG
Shen, JK
Luo, QZ
机构
[1] Univ Marburg, Neurochirurg Klin, Dept Neurosurg, D-35033 Marburg, Germany
[2] Shanghai Med Univ 2, Rui Jin Hosp, Dept Neurosurg, Shanghai, Peoples R China
[3] Shanghai Med Univ 2, Ren Ji Hosp, Dept Neurosurg, Shanghai, Peoples R China
关键词
loss of heterozygosity; NF2 gene mutation; Schwannomin/merlin expression; Vestibular Schwannoma;
D O I
10.1007/s11060-004-5176-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To analyze the molecular genetic alteration of sporadic vestibular schwannomas from the People's Republic of China and to correlate these alterations with the tumor behaviors. Methods: Four highly polymorphic microsatellite DNA markers were used to observe the frequency of loss of heterozygosity (LOH) in chromosome 22. The NF2 gene mutations were detected by Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and DNA sequencing. The schwannomin/merlin (S/M) expression was examined using anti-NF2 (A-19) IgG under immunohistochemistry and western blot. The proliferative index (LI) of vestibular schwannoma was evaluated by proliferative cell nuclear antigen investigation. Results: Sixteen vestibular schwannomas (44.4%) showed allele loss. We found 22 mutations in 36 schwannomas. The LI and the growth rate of schwannomas with LOH or mutation were significantly higher than those without LOH or mutation. All of these vestibular schwannomas showed no immunoreaction to anti-NF2(A-19) IgG by immunohistochemistry. By immunoblotting technique, reduced expression of S/M was found in 31 cases (86%). The growth index of schwannomas with severely reduced expression of S/M was significantly higher than those with moderately reduced or normal expression. Conclusion: The molecular genetic changes in sporadic vestibular schwannomas from Chinese patients were similar to the previous reports. We demonstrate the relationship between tumor behaviors and genetic alteration (including LOH and mutation of NF2 gene). We propose that inactivation of S/M, may be an important step in tumorigenesis of sporadic vestibular schwannoma.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 34 条
[1]   Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH) [J].
Antinheimo, J ;
Sallinen, SL ;
Sallinen, P ;
Haapasalo, H ;
Helin, H ;
Horelli-Kuitunen, N ;
Wessman, M ;
Sainio, M ;
Jääskeläinen, J ;
Carpén, O .
ACTA NEUROCHIRURGICA, 2000, 142 (10) :1099-1105
[2]   MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES [J].
BIANCHI, AB ;
HARA, T ;
RAMESH, V ;
GAO, JZ ;
KLEINSZANTO, AJP ;
MORIN, F ;
MENON, AG ;
TROFATTER, JA ;
GUSELLA, JF ;
SEIZINGER, BR ;
KLEY, N .
NATURE GENETICS, 1994, 6 (02) :185-192
[3]   Germline screening of the NF-2 gene in families with unilateral vestibular schwannoma [J].
Bikhazi, PH ;
Lalwani, AK ;
Kim, EJ ;
Bikhazi, M ;
Attaie, L ;
Slattery, WH ;
Jackler, RK ;
Brackmann, DE .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1998, 119 (01) :1-6
[4]   A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene [J].
Bruder, CEG ;
Ichimura, K ;
Tingby, O ;
Hirakawa, K ;
Komatsuzaki, A ;
Tamura, A ;
Yuasa, Y ;
Collins, VP ;
Dumanski, JP .
HUMAN GENETICS, 1999, 104 (05) :418-424
[5]   A G→A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2 [J].
De Klein, A ;
Riegman, PHJ ;
Bijlsma, EK ;
Heldoorn, A ;
Muijtjens, M ;
den Bakker, MA ;
Avezaat, CJJ ;
Zwarthoff, EC .
HUMAN MOLECULAR GENETICS, 1998, 7 (03) :393-398
[6]  
Fraenzer JT, 2003, INT J ONCOL, V23, P1493
[7]   Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas [J].
Gutmann, DH ;
Giordano, MJ ;
Fishback, AS ;
Guha, A .
NEUROLOGY, 1997, 49 (01) :267-270
[8]   Defects in neurofibromatosis 2 protein function can arise at multiple levels [J].
Gutmann, DH ;
Geist, RT ;
Xu, HM ;
Kim, JS ;
Saporito-Irwin, S .
HUMAN MOLECULAR GENETICS, 1998, 7 (03) :335-345
[9]  
Harwalkar JA, 1998, AM J OTOL, V19, P654
[10]   Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study [J].
Hitotsumatsu, T ;
Iwaki, T ;
Kitamoto, T ;
Mizoguchi, M ;
Suzuki, SO ;
Hamada, Y ;
Fukui, M ;
Tateishi, J .
ACTA NEUROPATHOLOGICA, 1997, 93 (03) :225-232